Connect Biopharma announced a collaboration with the Jovante Woods Foundation to expand its asthma education program nationwide across the U.S. The partnership aims to raise awareness and drive asthma education, with a specific focus on acute asthma attacks.
As part of the collaboration, Connect and the Foundation produced a video package to share Jovante Woods' story, inform the public about the dangers of acute asthma attacks, and communicate the importance of novel treatments. This initiative will be featured in an expanded schedule of community events and a social media campaign throughout the 2025 NFL season.
CEO Barry Quart stated that this focus on education aligns with the company's work in developing a new treatment for acute asthma exacerbations. The company is currently advancing its Phase 2 Seabreeze STAT studies, with topline data anticipated in the first half of next year.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.